SCHEMBL1243601

SCHEMBL1243601

CCOC(=O)c1cn(CC)c2cc(F)c(F)c(NCC(C)=O)c2c1=O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 2/20 0.46
STAT3 P40763 2/20 0.46
HTT P42858 2/20 0.45
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
ADRB2 P07550 1/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
FOXO1 Q12778 1/20 0.38
P2RX7 Q99572 2/20 0.38
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4116093 0.88 FOXO1 (0.48) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL25069803 0.87 KMT2A (0.48) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL1242688 0.87 KMT2A (0.50) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL1242783 0.85 LMNA (0.55) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL1243138 0.84 LMNA (0.46) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL8112020 0.83 KDM4E (0.54) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL25069717 0.83 KMT2A (0.47) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL1243960 0.81 KMT2A (0.51) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL1243131 0.81 KMT2A (0.50) LMNAKMT2AKDM4EALDH1A1HPGD
SCHEMBL1242619 0.80 FOXO1 (0.57) LMNAKMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879878-B2 such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation ASTELLAS PHARMA INC. (JP) 2011-02-01 US disclosed